Demonstrating specificity, tau seeding is not observed for extracts from Parkinson’s disease patients, suggesting that neurodegeneration alone is not sufficient to cause the observed seeding, which implies that brain samples from AD patients contain material capable of specifically seeding that is modulated by co-pathology. Here, MAPT is linked to Alzheimer disease.